An infrequent but nevertheless concerning complication associated with percutaneous transhepatic islet transplantation is bleeding. Historically in 61 procedures at this institution, we experienced four bleeding complications in three patients (6.6%), two requiring blood transfusion (3.3%) and two asymptomatic intraperitoneal bleeds detected sonographically at 24 h postprocedure (3.3%). It is suggested that the source of the majority of these bleeds is the liver parenchymal tract following removal of the infusion catheter combined with a significant dose of heparin administered to prevent portal vein thrombosis. Various techniques have been used to reduce the risk of tract bleeding, including gelfoam, intravascular coils, and cautery. In our experience gelfoam alone has been used to plug the catheter tract (n = 47); however, in the aforementioned three patients, this technique failed, either due to dislodgement of, or bleeding peripheral to, the plug. This article describes the use of D-Stat TM , a collagen/thrombin paste that is injected into the peripheral tract. In five consecutive cases performed using D-Stat TM , there has been no bleeding or thromboses detected. D-Stat TM combined with a single gelfoam plug offers a quick, easy, efficacious way of sealing the entire catheter tract without leaving any permanent hardware in the liver. This new method may simplify tract closure and reduce bleeding complications in islet transplantation.
INTRODUCTION Historical
Since the mid-1960s portography has been used in The recent success of islet transplantation has thrust it into the spotlight and has resulted in an increased the evaluation and treatment of liver diseases and their complications, and the percutaneous transhepatic route number of centers actively involved in clinical islet transplantation (15) (16) (17) ). An observation that has caused to access the portal vein rapidly became and has remained the technique of choice due to its ease and rela-concern is the occurrence of a small but significant number of serious bleeding complications that have been re-tive safety. The onset of the endoscopic era heralded the end of the use of portography for the treatment of esoph-ported related to the transplantation procedure (16,17). As islet transplant recipients are essentially "healthy" ageal varices; however, newer applications have emerged such as the preresection embolization of liver tumors, and islet transplantation in the United States is currently an experimental procedure, safety issues are of particu-treatment of complications of liver transplantation, and more recently islet transplantation. lar priority. In the most severe cases emergency blood transfusion and/or laparotomy has been required to treat Compared with large-volume studies evaluating the safety of percutaneous portal access in the treatment of the bleeding, which is typically from the catheter tract following catheter removal once the islet infusion is variceal hemorrhage, the bleeding rate in patients receiving islet transplants is similar, specifically 1.5-16% complete or from puncture sites of failed needle passes. We describe herein a new technique for sealing the tract (4, 5, 9, 13) dose of heparin (35-70 IU/kg) with the islet infusion, ing transfusion, in the same patient, was thought to be due to the large amount of heparin required (70 IU/kg which renders them temporarily anticoagulated during the procedure. due to a total tissue volume of 6 cc) and failure of the gelfoam plug, which was no longer visualized following Improvements in isolation techniques resulting in islet preparations of much lower individual particle size catheter removal. The bleeding was entirely intraperitoneal and ceased spontaneously following reversal of hepa-and tissue volume plus the recent introduction of the "bag method" for islet infusion (2) have both contributed to rin using protamine, but nevertheless required transfusion of 2 units of packed red blood cells during the acute reducing the risk of portal vein thrombosis. Nevertheless, the addition of heparin to the islet infusion remains event. Prompt intervention was possible due to early detection of bleeding on ultrasound immediately following essential primarily to further minimize this potentially lethal complication (10,18). Additionally, portal vein the procedure and perihepatic location confirmed bleeding from the tract. thrombosis, at a microscopic level, remains a concern as it has been shown that thrombus developing around the In two patients free intraperitoneal fluid was documented sonographically at 24 h, consistent with intra-intraportal islet can trigger the release of nonspecific inflammatory cytokines that are detrimental to islet sur-peritoneal bleeding that was asymptomatic. These patients had a fall in hemoglobin and hematocrit over the vival (3, 11, 14) . Heparin is added to the isolated islets as follows: if the total tissue volume is <5 cc, 35 IU hepa-subsequent week, which resolved spontaneously without sequelae. At that time the practice was to place one or rin/kg recipient body weight is added; if >5 cc the dose is doubled to 70 IU/kg (2450 and 4900 IU, respectively, two gelfoam plugs in the central tract and it is hypothesized that the catheter crossed another, more peripheral, in an average 70-kg patient). At 6 h following completion of infusion, 30 mg of enoxaparin (Lovenox  ) SC, venous radical and bleeding continued from the peripheral tract. BID is commenced for 7 days.
Islet Transplant Procedure D-Stat TM
D-Stat TM (Vascular Solutions Inc., Minneapolis, MN) Laparotomy approach with cannulation of a mesenteric vein was the approach first used in human islet is a flowable hemostat that has been approved as a topical and subcuticular closure device following vascular transplant recipients. Often a catheter was left in place for several days to allow several islet infusions. As suffi-puncture. The kit comprises thrombin vial (5000 U), collagen (200 mg), diluent vial (5 ml), mixing accessories cient islets were obtained from a single pancreas, most centers adopted the percutaneous approach, which could (10-ml syringe and needleless, noncoring vial access device), and applicator tips (Fig. 1) . The thrombin is a pro-be performed without general anesthesia and allowing a significantly more rapid recovery (1). This technique places tein substance produced through a conversion reaction in which prothrombin of bovine origin is activated by a temporary catheter into the portal vein that is removed upon completion of the single islet infusion. At this in-tissue thromboplastin of bovine origin in the presence of calcium chloride; it converts fibrinogen directly to fibrin stitution an Accustick TM II Introducer System (Boston Scientific) is used for portal vein access and islet infu-in the absence of intermediate physiological agents. The collagen is derived from purified bovine deep flexor ten-sion; the sheath has a 6 French (F) outer diameter (2 mm), 4.5 F inner diameter (1.5 mm) (1 F = 1/3 mm).
don; it attracts platelets that adhere to the fibrils, triggering platelet aggregation and thrombus formation in the Evaluation of Bleeding Complications interstices of the fibrous mass. The effect on platelet adhesion and aggregation is not inhibited by heparin in vitro. Since 1985 the Diabetes Research Institute has per-Perhaps the only contraindication is in patients with known formed 61 percutaneous transhepatic islet infusions sensitivity to bovine-derived materials. There is a theousing the bag infusion method. There have been no thromretical risk of development of anti-bovine antibodies; botic complications; however, we have identified bleedthis has not been demonstrated in pilot trials (personal ing associated with four procedures (6.6%). In two communication, Vascular Solutions). instances transfusion was required, both in the same patient (3.3%). The patient was subsequently investigated MATERIALS AND METHODS for bleeding diathesis, but no abnormality of coagulation was found.
In January 2003, the procedure was modified to ensure plugging of the entire catheter tract. Initially this was Further evaluation of the hemorrhagic complications requiring blood transfusion suggests in one procedure performed using gelfoam alone. However, the placement of multiple gelfoam plugs is cumbersome if not impossi-bleeding was due to multiple passes required to obtain access to the portal vein and the bleeding was intra-ble through smaller catheters, so a new injectable agent, D-Stat TM , was investigated for tract closure. Subsequent hepatic and subcapsular. The second hemorrhage requir- patients undergoing percutaneous islet transplantation alized at the end of the catheter, and injection is then slowly continued while simultaneously withdrawing the underwent sealing of the catheter tract with a combination of a single gelfoam plug followed by D-Stat TM injec-catheter until it is completely removed so that the entire remainder of the tract is filled. The linear density can be tion to seal the entire peripheral tract.
For preparation the thrombin is dissolved in the dilu-easily visualized following catheter removal, confirming stable position (Fig. 2) . tion fluid, which is then mixed with the collagen to form a paste-like mixture. Up to half of the dilution fluid can RESULTS be replaced with contrast for fluoroscopic visualization.
It requires 2-3 min for preparation and can be prepared
Since the procedure has been modified to include sealing of the entire catheter tract there have been no up to 3 h prior to application. The D-Stat TM so produced has the consistency of toothpaste.
further bleeding complications (11 cases). In six of these patients gelfoam alone was utilized; patients required To seal the catheter tract, the infusion catheter is first retracted under fluoroscopic monitoring until the tip lies two to four plugs and time taken for tract closure was prolonged. within the parenchymal tract; this can be ascertained when injected contrast does not flow away, but remains
In five patients a single gelfoam plug was combined with injection of D-Stat TM (Fig. 2 ). This method was as a linear density within the liver parenchyma. To place the initial gelfoam plug, a dry plug is manually placed quick and simple to perform. The plug and D-Stat TMsealed portions of the tract could be easily identified at into the luer of a 1-cc syringe filled with contrast. The syringe is attached the end of the infusion catheter and the end of the procedure. There was no dislodgement of the D-Stat TM and no bleeds or thrombotic complications the plug injected into the proximal catheter; care is taken not to inject into the liver. The plug is then further ad-were identified in any patient. Patients tolerated this modification well; one patient vanced to the end of the catheter using a pusher and then "deployed" by withdrawing the catheter over the pusher experienced significant pain during catheter withdrawal and injection of D-Stat TM , likely due to minimal subcap-to release the plug(s). The gelfoam plug should be visible and stable fluoroscopically and no further blood re-sular injection of the D-Stat TM . This resolved within minutes with a small amount of additional intravenous nar-turn should be noted from the catheter. The D-Stat TM syringe is then simply connected to the end of the infu-cotic administration. Immediate US evaluation demonstrates the gelfoam sion catheter, D-Stat TM is slowly injected until it is visu- plugs and D-Stat TM material as linear bright echoes in tract bleeding. Clearly plugging of the catheter tract is essential if bleeding complications are to be further min-the liver parenchyma likely due to the air within the mixture. In all patients the D-Stat TM and/or gelfoam was no imized. Gelfoam alone can be used but has been demonstrated to fail in some cases either due to antegrade longer visible at the 24-h ultrasound evaluation. movement into a portal or hepatic vein, or due to retro-DISCUSSION grade movement into the peritoneal cavity, and it can Constant evaluation of the islet transplant procedure be cumbersome to perform. If the tract is short due to is performed at our institution. Previous procedure reperipheral portal vein access, the catheter can become finements included the introduction of ultrasound guiddislodged with respiratory motion before adequate plugance to reduce the number of needle passes required to ging is achieved. If only a portion of the tract is plugged, gain access to the portal vein (6) . This was successful but bleeding can occur from the peripheral tract. The placedid not prevent the occurrence of intraperitoneal bleeds. ment of one plug and injection of D-Stat TM in the re-When considering ways to prevent bleeding complimainder of the tract is quick and seems to be efficacious. cations alternative transplant approaches were consid-Other centers have reported sealing the tract using ered. A return to the laparotomy approach or use of a coil and gelfoam combinations and a cauterizing needle recently described laparoscopic approach (12) would be (J. Shapiro & B. Hering, personal communication). extremely safe from the perspective of bleeding; how-Coils have the advantage that they are difficult to disever, there remains the risk of anesthetic complications lodge and hold the gelfoam in place. The disadvantages and a protracted recovery period. An alternative percutaof coils, however, include that they remain permanently, neous approach is the transjugular intrahepatic portal could potentially be a source of infection, degrade future systemic route (TIPSS) with passage of a needle from imaging studies such as MRI or CT due to metallic artithe right hepatic vein to a branch of the right portal vein. fact, and are expensive. D-Stat TM resorbs entirely by 24 Experience with this approach in healthy individuals is h; it is relatively inexpensive and easier to use. Potential rare, more usually it is used to create a portosystemic pitfalls include activation of the clotting system by thromshunt in patients with portal hypertension and bleeding bin; however, in the small numbers of cases we have varices. We have hesitated using this technique due to done we have not seen any evidence of this at 24 h or the increased complexity and no guarantee that compliat 7 days, and function of transplanted islets has been cations would be reduced.
comparable to other infusions. We believe that D-Stat TM We, like other centers, have focused instead on improvides a safe and efficacious alternative to more comproving the current technique by addressing the most plex possibilities for closure of the catheter tract followcommon cause of bleeding and its prevention, namely ing islet infusion and may be of assistance to reduce the
